logo
Share SHARE
FONT-SIZE Plus   Neg

Roche Says Disappointed With ISS Recommendation

Swiss drugmaker Roche (RHHBY.PK) said Friday that it is disappointed with Institutional Shareholder Services' recommendation that shareholders of U.S.-based Illumina, Inc. (ILMN: Quote) vote against the election of Roche's independent director nominees to Illumina's Board of Directors at Illumina's 2012 Annual Meeting of Stockholders to be held on April 18.

"While we are disappointed that ISS has recommended that Illumina shareholders vote against our director nominees at the Illumina annual meeting, we are pleased that ISS noted that 'Roche would seem to be an excellent partner for Illumina as the sequencing industry grows more intertwined with new drug development.' ISS also noted that the key to Illumina's valuation falls in its commercialization strategy - a strategy that has not been tested but is an area in which we believe Roche could provide significant expertise," Severin Schwan, CEO of Roche Group, said in a statement. "We respectfully challenge ISS' assertion that our current 'bid does not provide a compelling starting point for negotiations.' Our goal has always been to enter into a negotiated transaction with Illumina and we firmly believe that our present offer is more than adequate to serve as a basis for negotiation with Illumina," Schwan added.

Schwan further said, "We remain willing to consider additional value if given the opportunity to enter discussions and perform due diligence."

In late January, Roche commenced a tender offer to acquire all shares of Illumina for $44.50 per share in cash. The offer was raised to $51.00 per share in cash on March 29. But the Illumina board has cited the company's growth prospects in the next generation sequencing market and rebuffed the sweetened offer as grossly inadequate.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fortune has once again named Google Inc. (GOOG, GOOGL) as the best company to work for, with Twitter Inc. (TWTR) also joining the annual list for the first time. This is for the sixth time and for the fourth consecutive time that Google has ranked No.1 in the Fortune's annual list of "100 Best Companies... Dunkin' Donuts has agreed to remove a whitening agent called titanium dioxide, commonly a source of nanomaterials, from all powdered sugar used in its donuts. The move follows pressure from advocacy group As You Sow, which put a shareholder proposal asking Dunkin' to reduce the risks of using nanomaterials in its food products. Warren Buffett's Berkshire Hathaway is reportedly planning its first ever European bond sale of 3 billion euros to take advantage of low interest rates in the region, traversing a path taken by a range of home companies in search of cheap funding options. The move comes as the European Central Bank's bond-buying stimulus program of 60 billion euros a month is imminent.
comments powered by Disqus
Follow RTT